Harvard – Tectonic Therapeutic, License Agreement Post author:GHIAA Admin Post published:June 30, 2025 Post category: Continue ReadingHarvard – Tectonic Therapeutic, License Agreement
Harvard – Tectonic Therapeutic, License Agreement Post author:GHIAA Admin Post published:June 30, 2025 Post category: Continue ReadingHarvard – Tectonic Therapeutic, License Agreement
Harvard – Tectonic Therapeutic, License Agreement Post author:GHIAA Admin Post published:June 30, 2025 Post category: Continue ReadingHarvard – Tectonic Therapeutic, License Agreement
Atreca – Gates Medical Research Institute, Malaria Monoclonal Antibodies License Agreement Post author:GHIAA Admin Post published:June 26, 2025 Post category: Continue ReadingAtreca – Gates Medical Research Institute, Malaria Monoclonal Antibodies License Agreement
Atreca – Gates Medical Research Institute, Malaria Monoclonal Antibodies License Agreement Post author:GHIAA Admin Post published:June 26, 2025 Post category: Continue ReadingAtreca – Gates Medical Research Institute, Malaria Monoclonal Antibodies License Agreement
Atreca – Gates Medical Research Institute, Malaria Monoclonal Antibodies License Agreement Post author:GHIAA Admin Post published:June 26, 2025 Post category: Continue ReadingAtreca – Gates Medical Research Institute, Malaria Monoclonal Antibodies License Agreement
MedinCell – MPP, Malaria Vector Control (mdc-STM/ivermectin formulation) License Agreement Post author:GHIAA Admin Post published:June 18, 2025 Post category: Continue ReadingMedinCell – MPP, Malaria Vector Control (mdc-STM/ivermectin formulation) License Agreement
MedinCell – MPP, Malaria Vector Control (mdc-STM/ivermectin formulation) License Agreement Post author:GHIAA Admin Post published:June 18, 2025 Post category: Continue ReadingMedinCell – MPP, Malaria Vector Control (mdc-STM/ivermectin formulation) License Agreement
MedinCell – MPP, Malaria Vector Control (mdc-STM/ivermectin formulation) License Agreement Post author:GHIAA Admin Post published:June 18, 2025 Post category: Continue ReadingMedinCell – MPP, Malaria Vector Control (mdc-STM/ivermectin formulation) License Agreement